Robert M. Plenge

CIK: 0001773367

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)7 (26.9%)

Derivative conversions

Awards (A)5 (19.2%)

Compensation grants

Other (G, F, J, C, D, …)14 (53.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

BMRN

BIOMARIN PHARMACEUTICAL INC

Director

BMY

BRISTOL MYERS SQUIBB CO

Officer

Discretionary Trading P&L

Holdings

Transaction History (26 total)

BMRN
BIOMARIN PHARMACEUTICAL INC
Sep 10, 2026
Award(A)
Direct
6.1K shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2026
Award(A)
Performance Shares
Direct
26.9K shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2026
Exercise(M)
Direct
1.1K shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2026
Other(J)
Direct
124 shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2026
Tax Payment(F)
Direct
436 shares at avg. $60.13$26K
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2026
Exercise(M)
Direct
2.3K shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2026
Other(J)
Direct
253 shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2026
Tax Payment(F)
Direct
927 shares at avg. $60.13$56K
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2026
Exercise(M)
Direct
14.1K shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2026
Other(J)
Direct
6.9K shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2026
Tax Payment(F)
Direct
3.2K shares at avg. $60.13$191K
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2026
Award(A)
Market Share Units
Direct
18K shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Exercise(M)
Direct
1.2K shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Other(J)
Direct
80 shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Award(A)
Market Share Units
Direct
23.4K shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Award(A)
Performance Shares
Direct
35.1K shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Tax Payment(F)
Direct
482 shares at avg. $63.11$30K
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Exercise(M)
Direct
1.1K shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Other(J)
Direct
193 shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Tax Payment(F)
Direct
406 shares at avg. $63.11$26K
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Exercise(M)
Direct
2.3K shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Other(J)
Direct
399 shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Tax Payment(F)
Direct
862 shares at avg. $63.11$54K
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Exercise(M)
Direct
6.6K shares-
BMY
BRISTOL MYERS SQUIBB CO
Mar 10, 2025
Other(J)
Direct
2.4K shares-

		Type	Shares	Price		Ownership
Sep 10, 2026	BMRN BIOMARIN PHARMACEUTICAL INC	Award(A)	6,140	-	$0	Direct
Mar 10, 2026	BMY BRISTOL MYERS SQUIBB CO	Award(A) Performance Shares	26,939	-	-	Direct
Mar 10, 2026	BMY BRISTOL MYERS SQUIBB CO	Exercise(M)	1,107	-	$0	Direct
Mar 10, 2026	BMY BRISTOL MYERS SQUIBB CO	Other(J)	124	-	$0	Direct
Mar 10, 2026	BMY BRISTOL MYERS SQUIBB CO	Tax Payment(F)	436	$60.13	$26,217	Direct
Mar 10, 2026	BMY BRISTOL MYERS SQUIBB CO	Exercise(M)	2,342	-	$0	Direct
Mar 10, 2026	BMY BRISTOL MYERS SQUIBB CO	Other(J)	253	-	$0	Direct
Mar 10, 2026	BMY BRISTOL MYERS SQUIBB CO	Tax Payment(F)	927	$60.13	$55,741	Direct
Mar 10, 2026	BMY BRISTOL MYERS SQUIBB CO	Exercise(M)	14,052	-	$0	Direct
Mar 10, 2026	BMY BRISTOL MYERS SQUIBB CO	Other(J)	6,900	-	$0	Direct
Mar 10, 2026	BMY BRISTOL MYERS SQUIBB CO	Tax Payment(F)	3,172	$60.13	$190,732	Direct
Mar 10, 2026	BMY BRISTOL MYERS SQUIBB CO	Award(A) Market Share Units	17,959	-	-	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Exercise(M)	1,165	-	-	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Other(J)	80	-	-	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Award(A) Market Share Units	23,431	-	-	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Award(A) Performance Shares	35,146	-	-	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Tax Payment(F)	482	$63.11	$30,419	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Exercise(M)	1,107	-	-	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Other(J)	193	-	-	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Tax Payment(F)	406	$63.11	$25,623	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Exercise(M)	2,342	-	-	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Other(J)	399	-	-	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Tax Payment(F)	862	$63.11	$54,401	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Exercise(M)	6,641	-	-	Direct
Mar 10, 2025	BMY BRISTOL MYERS SQUIBB CO	Other(J)	2,449	-	-	Direct

1-25 of 26 transactions

About Plenge Robert M

Plenge Robert M (SEC CIK 0001773367) files insider reports with the SEC as Director of BIOMARIN PHARMACEUTICAL INC (BMRN) and EVP, Chief Research Officer of BRISTOL MYERS SQUIBB CO (BMY).

Signal8 holds 4 ownership filings by Plenge Robert M (1 Form 3, 3 Form 4), filed between Mar 12, 2025 and Sep 14, 2026. Those filings report 26 transactions, from Mar 10, 2025 to Sep 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Plenge Robert M's filings is in SAN RAFAEL, CA.

Recent filings by Plenge Robert M

Sep 10, 2026: Grant or award of BMRN shares (Form 4, code A).
Mar 10, 2026: Grant or award of BMY derivative securities (Form 4, code A).
Mar 10, 2026: Option exercise of BMY shares (Form 4, code M).
Mar 10, 2026: Other transaction of BMY shares (Form 4, code J).
Mar 10, 2026: Tax withholding of BMY shares (Form 4, code F).

Other insiders filing for BIOMARIN PHARMACEUTICAL INC (BMRN)

Friberg Gregory R, EVP, Chief R&D Officer
Davis George Eric, EVP, Chief Legal Officer
Countouriotis Athena, Director
Walbert Timothy P, Director
Ho Maykin, Director
HOMBACH ROBERT J., Director

How to read Form 4 transaction codes